###begin article-title 0
Histo-Blood Group Gene Polymorphisms as Potential Genetic Modifiers of Infection and Cystic Fibrosis Lung Disease Severity
###end article-title 0
###begin p 1
Conceived and designed the experiments: JLTC MAZ LHB RGP MLD HF BWW MRK. Performed the experiments: JLTC RGP. Analyzed the data: JLTC LHB MLD HC HF FW MRK. Contributed reagents/materials/analysis tools: MAZ LHB BWW. Wrote the paper: JLTC MRK.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 405 413 <span type="species:ncbi:9606">patients</span>
The pulmonary phenotype in cystic fibrosis (CF) is variable; thus, environmental and genetic factors likely contribute to clinical heterogeneity. We hypothesized that genetically determined ABO histo-blood group antigen (ABH) differences in glycosylation may lead to differences in microbial binding by airway mucus, and thus predispose to early lung infection and more severe lung disease in a subset of patients with CF.
###end p 3
###begin title 4
Methods and Principal Findings
###end title 4
###begin p 5
###xml 918 940 910 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 99 107 <span type="species:ncbi:9606">Patients</span>
###xml 885 893 <span type="species:ncbi:9606">patients</span>
###xml 918 940 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Clinical information and DNA was collected on >800 patients with the DeltaF508/DeltaF508 genotype. Patients in the most severe and mildest quartiles for lung phenotype were enrolled. Blood samples underwent lymphocyte transformation and DNA extraction using standard methods. PCR and sequencing were performed using standard techniques to identify the 9 SNPs required to determine ABO blood type, and to identify the four SNPs that account for 90-95% of Lewis status in Caucasians. Allele identification of the one nonsynonymous SNP in FUT2 that accounts for >95% of the incidence of nonsecretor phenotype in Caucasians was completed using an ABI Taqman assay. The overall prevalence of ABO types, and of FUT2 (secretor) and FUT 3 (Lewis) alleles was consistent with that found in the Caucasian population. There was no difference in distribution of ABH type in the severe versus mild patients, or the age of onset of Pseudomonas aeruginosa infection in the severe or mild groups. Multivariate analyses of other clinical phenotypes, including gender, asthma, and meconium ileus demonstrated no differences between groups based on ABH type.
###end p 5
###begin title 6
Conclusions and Significance
###end title 6
###begin p 7
###xml 161 174 161 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 161 174 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 265 273 <span type="species:ncbi:9606">patients</span>
Polymorphisms in the genes encoding ABO blood type, secretor or Lewis genotypes were not shown to associate with severity of CF lung disease, or age of onset of P. aeruginosa infection, nor was there any association with other clinical phenotypes in a group of 808 patients homozygous for the DeltaF508 mutation.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 135 138 135 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Bobadilla1">[1]</xref>
###xml 187 190 187 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Riordan1">[2]</xref>
###xml 308 311 308 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Cystic1">[3]</xref>
###xml 393 396 377 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Bobadilla1">[1]</xref>
###xml 710 713 694 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Cutting1">[4]</xref>
###xml 715 718 699 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Boyle1">[5]</xref>
Cystic fibrosis (CF) is the most common life shortening genetic disorder in Caucasians, and occurs in 1 in 3200 Caucasians in the U.S. [1] Since the identification of the CF gene in 1989 [2], over 1500 mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) have been associated with CF. [3] The most common mutation, DeltaF508, occurs in approximately70% of CFTR alleles. [1] Although numerous mutations in the CF gene have been described, there is little correlation between the specific mutation in the CF gene and severity of pulmonary disease. Recent investigations have focused on the identification of other non-CF gene variants that may affect the phenotype, i.e. "modifier genes." [4], [5]
###end p 9
###begin p 10
###xml 192 195 192 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Knowles1">[6]</xref>
###xml 327 330 327 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Gibson1">[7]</xref>
###xml 332 335 332 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Li1">[8]</xref>
###xml 446 449 446 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Wat1">[9]</xref>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Wang1">[10]</xref>
Mutations in CFTR cause CF, and the initial pathophysiology of the lung disease involves defective ion transport, dehydration of the mucous layer, and reduced mucociliary and cough clearance. [6] These abnormalities lead to chronic bacterial infection, which is the key factor in the morbidity and mortality of CF lung disease [7], [8]; additionally, respiratory viral infections are associated with exacerbation and progression of lung disease. [9], [10]
###end p 10
###begin p 11
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Marionneau1">[11]</xref>
###xml 665 672 665 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004270.s001">Text S1</xref>
###xml 677 686 677 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004270.s002">Figure S1</xref>
###xml 965 969 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Yip1">[12]</xref>
Bacteria and viruses bind to mucins and the cellular glycocalyx of airway epithelia based on their glycosylation patterns[11]; thus, genetically based differences in patterns of glycosylation and microbial binding may increase the likelihood of airway infection, and contribute to progression of airway damage, and severity of lung disease. One cause of variability in glycosylation of airway epithelia is inherited blood type, which reflects genetic-based differences in glycosylation enzymes. The histo-blood group antigens, ABO, H, and Lewis, are formed by the action of glycosyltransferases to attach sugar molecules to disaccharide precursors. (See Supplement Text S1 and Figure S1.) Addition of fucose to these disaccharide precursors creates the H antigen, and further modification to the H antigen by glycosyltransferases leads to synthesis of the blood group antigens encoded by the ABO ("blood type") gene. The O allele does not produce an active enzyme. [12]
###end p 11
###begin p 12
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Marionneau1">[11]</xref>
Formation of other histo-blood group antigens is dependent on fucosyltransferases. The FUT2 "secretor" gene encodes the fucosyltransferase that synthesizes the H antigen. Loss-of-function mutations in FUT2 (secretor gene) lead to an absence of ABH antigens in the lung, saliva, and gut, resulting in the "non-secretor" phenotype. Loss-of-function mutations in the FUT3 (Lewis) gene result in the Lewis negative phenotype. [11]
###end p 12
###begin p 13
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Marionneau1">[11]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Huang1">[13]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Marionneau2">[14]</xref>
###xml 486 495 486 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 522 526 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Saadi1">[15]</xref>
###xml 532 545 532 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Wu1">[16]</xref>
###xml 917 921 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Cohen1">[17]</xref>
###xml 923 927 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Kauffmann1">[18]</xref>
###xml 929 933 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Ronchetti1">[19]</xref>
###xml 347 353 <span type="species:ncbi:9606">humans</span>
###xml 383 396 <span type="species:ncbi:11983">Norwalk virus</span>
###xml 486 495 <span type="species:ncbi:1280">S. aureus</span>
###xml 532 545 <span type="species:ncbi:287">P. aeruginosa</span>
The ABO gene is highly polymorphic, which is thought to be related to evolutionary changes for host-pathogen interactions, as many pathogens utilize surface glycoproteins in host invasion. [11] There is correlation with ABH status and infection with bacteria and viruses; for example, numerous studies have shown that the binding and infection of humans with noroviruses (previously Norwalk virus,) is dependent on ABO and secretor phenotype. [13], [14] Furthermore, certain strains of S. aureus bind to the Lewis antigen [15], and P. aeruginosa has a lectin, PA-IIL, that is fucose-specific. [16] Thus, genetic-based differences in glycosylation that determine blood type can also predispose to an increased likelihood of bacterial and/or viral binding and infection in the airways. Additionally, polymorphisms in the genes coding for the ABH antigens are associated with airway diseases, including COPD and asthma. [17], [18], [19]
###end p 13
###begin p 14
###xml 380 394 380 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa.</italic>
###xml 265 273 <span type="species:ncbi:9606">patients</span>
###xml 380 393 <span type="species:ncbi:287">P. aeruginosa</span>
We speculated that genetic predisposition to different patterns of glycosylation in the ABH pathway would lead to early chronic lung infection in CF, and therefore, more severe progression of disease. We tested the genotype of key (ABH) glycosylation enzymes in CF patients with "severe" versus "mild" lung disease, and tested for associations with age of onset of infection with P. aeruginosa.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Objectives
###end title 16
###begin p 17
Establish ABO, FUT2 and FUT3 genotype for each subject
###end p 17
###begin p 18
Determine whether differences in ABH type predict differences in lung phenotype.
###end p 18
###begin p 19
We hypothesized that subjects with ABH types with more glycosylation (i.e. blood groups A, and B, and secretor and Lewis positive phenotypes) would be more likely to have severe lung phenotype as a result of having an increased predisposition to early viral/bacterial infection.
###end p 19
###begin title 20
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
Participants
###end title 20
###begin p 21
###xml 148 152 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Drumm1">[20]</xref>
###xml 188 189 184 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 290 291 286 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 390 392 386 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1.</sub>
###xml 537 541 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Schluchter1">[21]</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
###xml 153 161 <span type="species:ncbi:9606">Patients</span>
Patients with Cystic Fibrosis homozygous for the DeltaF508 CF gene mutation were enrolled from 44 sites (n = 808 patients) as previously published. [20] Patients were enrolled based on FEV1 values in the lowest quartile ("severe;" n = 263) or highest quartile ("mild;" n = 545) for age. FEV1 data has been analyzed according to biostatistical models based on longitudinal lung function (FEV1.) This modeling has robust power to predict survival; hence the use of multiple spirometric values is a strong surrogate for long-term outcomes. [21]
###end p 21
###begin title 22
Description of Procedures
###end title 22
###begin title 23
Data Collection
###end title 23
###begin p 24
###xml 5 12 <span type="species:ncbi:9606">patient</span>
Each patient received a unique identifier code to maintain confidentiality. Source documents were collected for pulmonary function tests, meconium ileus history and sputum microbiology. Case report forms were used to collect information about the presence of diabetes mellitus, steroid use, oral hypoglycemic and insulin use.
###end p 24
###begin title 25
Source of DNA
###end title 25
###begin p 26
###xml 128 136 <span type="species:ncbi:9606">patients</span>
Whole blood in sodium citrate (for DNA extraction) and heparinized (for lymphocyte transformation) tubes was collected from all patients at the time of study enrollment. DNA was extracted and stored using standard methodology in the central molecular pathology facility at University of North Carolina-Chapel Hill (UNC) Hospitals. DNA and transformed lymphocytes were stored frozen in two different storage containers at two separate sites with continuous monitoring.
###end p 26
###begin title 27
ABO Genotyping
###end title 27
###begin p 28
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Yip1">[12]</xref>
###xml 334 341 334 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004270.s001">Text S1</xref>
###xml 346 354 346 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004270.s004">Table S1</xref>
###xml 607 614 603 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004270.s001">Text S1</xref>
###xml 619 627 615 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004270.s005">Table S2</xref>
Sequence variation in 7 ABO alleles accounts for >90% of the variants in white Europeans. [12] Primers were designed to amplify three fragments from exons 6 and 7 containing the 9 SNPs (rs8176719, rs8176720, rs1053878, rs7853989, rs8176740, rs8176741, rs8176742, rs816750, rs8176472) necessary to identify blood type. (See Supplement Text S1 and Table S1 for primer sequences.) PCR was performed using standard techniques, and high throughput sequencing was performed on an ABI Prism(R) 3730 Genetic Analyzer. Batch data analysis was performed with SNP finding via the Polyphred(c) program. (See Supplement Text S1 and Table S2 for sequence variation information used to construct ABO phenotype.)
###end p 28
###begin title 29
FUT2 Genotyping
###end title 29
###begin p 30
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Svensson1">[22]</xref>
Loss of function mutations in FUT2 (non-secretor) occur in 20% of European-derived Caucasians. In Caucasians, one nonsynonymous SNP in FUT2 (G428A, rs601338) accounts for >95% of the incidence of nonsecretor phenotype. [22] Allele identification was performed using an ABI Taqman(c) assay on an ABI Prism(R) 7700HT/7900HT Sequence Detection System.
###end p 30
###begin title 31
FUT3 Genotyping
###end title 31
###begin p 32
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Salomaa1">[23]</xref>
###xml 390 394 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Cameron1">[24]</xref>
###xml 396 400 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Pang1">[25]</xref>
Loss of function mutations in FUT3 (Lewis negative) occur in 10% of European-derived Caucasians. SNPs in four positions (T59G, rs28362459; T202C, rs812936; C314T, rs778986; and T1067A, rs3894326) account for 90-95% of Lewis status in Caucasians. [23] Primers were designed for PCR amplification, and sequencing of the FUT3 gene was performed on an ABI Prism(R) 3130xl/310 Genetic Analyzer. [24], [25]
###end p 32
###begin title 33
###xml 15 28 15 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 15 28 <span type="species:ncbi:287">P. aeruginosa</span>
Acquisition of P. aeruginosa
###end title 33
###begin p 34
###xml 196 209 196 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 330 343 330 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 196 209 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 228 236 <span type="species:ncbi:9606">patients</span>
###xml 330 343 <span type="species:ncbi:287">P. aeruginosa</span>
In addition to lung function data, all available CFF registry data on study subjects that related to respiratory tract (oropharyngeal and sputum) cultures was acquired. Age of onset of persistent P. aeruginosa infection for all patients was established with available culture data (n = 674), and defined as the first age at which P. aeruginosa was present in respiratory cultures in two consecutive, or two out of three years.
###end p 34
###begin title 35
Ethics
###end title 35
###begin p 36
###xml 95 106 <span type="species:ncbi:9606">participant</span>
This study was approved by Institutional Review Boards at all participating institutions. Each participant provided written informed consent prior to study participation. The study is registered in the ClinicalTrials.gov database: NCT00037765.
###end p 36
###begin title 37
Statistical Methods
###end title 37
###begin p 38
###xml 907 920 907 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1152 1165 1150 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 907 920 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1152 1165 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1253 1261 <span type="species:ncbi:9606">patients</span>
To test for associations between severity of lung disease, key clinical phenotypes, and polymorphisms in ABH genotypes, Fisher's exact test was used. All tests were two-sided. To investigate the effect of blood group alleles (ABO genotype, nonsecretor phenotype, and FUT3 genotypes producing Lewis negative phenotypes) on CF lung severity risk, we performed multiple logistic regression analyses to predict severity status. The number of A and B antigen alleles was included in an additive model on the log-odds of severe lung status, as well as the FUT2 and FUT3 genotypes, and terms to account for possible interaction between the genes. In addition, the following predictors were used in the model: gender, meconium ileus, asthma, and the TGFb1 codon 10 CC genotype (previously shown to be associated with severe lung disease.) In order to determine whether ABH type influenced the age of acquisition of P. aeruginosa, Kaplan-Meier analysis was performed using SigmaStat(R) software. ABO type, and secretor and Lewis status were evaluated in the mild versus severe groups. Additionally, to address the possibility of age confounding the analysis of P. aeruginosa acquisition, ABH types were also analyzed in the severe group versus the group of mild patients who were aged 15-28 years ("young milds,") and interactions among the three ABH types were analyzed. Allelic comparison that yielded a statistical significance of </=0.05 was considered significant. Unadjusted p-values are reported.
###end p 38
###begin title 39
Results
###end title 39
###begin title 40
###xml 23 31 <span type="species:ncbi:9606">patients</span>
Characteristics of the patients
###end title 40
###begin p 41
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Drumm1">[20]</xref>
###xml 326 327 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 609 613 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Drumm1">[20]</xref>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
###xml 148 156 <span type="species:ncbi:9606">patients</span>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
###xml 406 414 <span type="species:ncbi:9606">patients</span>
###xml 569 577 <span type="species:ncbi:9606">patients</span>
As previously reported, pulmonary and nutrition characteristics of the patients classified as severe (n = 263) were markedly different than that of patients classified as mild (n = 545.) [20] Although the mean age of the patients in the mild group was 28.6 +/- 9.7 years compared to 16.2 +/- 4.2 years in the severe group, FEV1 was more than 25% higher and body mass index percentile was 24% higher in the patients in the mild group versus those in the severe group (p<0.001). Gender, prevalence of diabetes mellitus (adjusted for age), and asthma were similar between patients in the mild and severe groups. [20]
###end p 41
###begin title 42
ABO genotype
###end title 42
###begin p 43
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Harmening1">[26]</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-dbSNP1">[27]</xref>
###xml 215 222 215 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004270.s001">Text S1</xref>
###xml 227 235 227 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004270.s006">Table S3</xref>
###xml 367 374 367 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004270-t001">Table 1</xref>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 322 330 <span type="species:ncbi:9606">patients</span>
###xml 505 513 <span type="species:ncbi:9606">patients</span>
###xml 543 551 <span type="species:ncbi:9606">patients</span>
ABO genotype was successfully determined for 778 patients. ABO allele frequencies, and resultant ABO blood groups were consistent with the reported prevalence in the Caucasian population. [26], [27] (See Supplement Text S1 and Table S3.) We saw no significant difference in blood type distribution between mild and severe patients by Fisher exact test. (p = 0.446). (Table 1) We also saw no significant associations when ABO allele distribution was analyzed in the following subgroups: males and females, patients with and without asthma, and patients with and without history of meconium ileus. (Data not shown.)
###end p 43
###begin title 44
###xml 49 56 <span type="species:ncbi:9606">patient</span>
Prevalence of ABO blood types in severe and mild patient groups.
###end title 44
###begin p 45
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Harmening1">[26]</xref>
###xml 253 260 253 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004270.s001">Text S1</xref>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
ABO allele frequencies and resultant ABO phenotypes were consistent with known prevalence in the Caucasian population. [26] There is no significant difference in blood type distribution amongst mild and severe patients, or in any subgroup analysis (see Text S1) by Fisher exact test. (n = 778, p = 0.446)
###end p 45
###begin title 46
FUT2 genotype
###end title 46
###begin p 47
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-dbSNP1">[27]</xref>
###xml 338 345 338 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004270-t002">Table 2</xref>
###xml 443 450 443 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004270-t002">Table 2</xref>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
###xml 294 302 <span type="species:ncbi:9606">patients</span>
FUT2 ("secretor/nonsecretor") alleles for SNP G428A (rs601338) were successfully determined in 806 patients. The distribution of alleles was consistent with that found in the Caucasian population. [27] There was no significant difference in secretor status distribution between mild and severe patients by Fisher exact test (p = 0.569). (Table 2) Subgroup analysis by gender, asthma and meconium ileus status did not reveal any associations. (Table 2)
###end p 47
###begin title 48
###xml 69 76 <span type="species:ncbi:9606">patient</span>
Prevalence of FUT2 and FUT3 alleles and genotypes in severe and mild patient groups.
###end title 48
###begin p 49
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-dbSNP1">[27]</xref>
###xml 314 326 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
###xml 197 205 <span type="species:ncbi:9606">patients</span>
FUT2 and FUT3 allele frequencies and genotypes, and resultant phenotypes were consistent with that known for the Caucasian population. [27] There is no association between lung disease severity in patients homozygous for the DeltaF508 mutation and individual FUT2 or FUT 3 SNPs, nor with secretor or Lewis status. section sign P-values generated by Fisher exact test.
###end p 49
###begin title 50
FUT3 genotype
###end title 50
###begin p 51
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Salomaa1">[23]</xref>
###xml 325 332 325 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004270-t002">Table 2</xref>
###xml 442 446 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Orntoft1">[28]</xref>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Salomaa1">[23]</xref>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
###xml 241 249 <span type="species:ncbi:9606">patients</span>
Four SNPs account for 90-95% of Lewis status in Caucasians. [23] FUT 3 alleles were successfully determined at these four loci for 707 patients. There was no significant difference for individual SNPs between mild versus severe lung disease patients, nor by gender, meconium ileus or asthma status by Fisher exact test. (See Table 2.) Orntoft et al correlated FUT3 gene mutations with enzyme activity and circulating levels of sialyl-Lewis a [28]; therefore, the SNPs were analyzed in groups consistent with Lewis negative or positive phenotypes, but no significant differences were observed. (Data not shown.) [23]
###end p 51
###begin title 52
ABH Type
###end title 52
###begin p 53
###xml 364 377 364 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 379 392 379 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. influenzae</italic>
###xml 397 406 397 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Saadi1">[15]</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Rhim1">[29]</xref>
###xml 1068 1075 1068 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004270.s001">Text S1</xref>
###xml 1080 1088 1080 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004270.s007">Table S4</xref>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 364 377 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 379 392 <span type="species:ncbi:727">H. influenzae</span>
###xml 397 406 <span type="species:ncbi:1280">S. aureus</span>
###xml 603 611 <span type="species:ncbi:9606">patients</span>
We anticipated that the A, B or AB blood group, secretor (FUT2) and Lewis positive (FUT3) genotypes would be found in higher prevalence in patients with severe lung phenotype, because genotypes associated with functional fucosyltransferases for synthesis of pertinent glycoproteins have been shown to be associated with increased propensity towards infection with P. aeruginosa, H. influenzae and S. aureus. [15], [29] Conversely, we thought that O blood group, non-secretor and Lewis negative genotypes (genotypes that lack or produce nonfunctional fucosyltransferases) would have higher prevalence in patients with mild phenotypes, reflecting a reduced risk of infection. In order to evaluate the effect of ABH type (A, B, AB, or O blood type, secretor status, and Lewis status) on risk for severe lung disease, multiple logistic regression was performed using the severity phenotype as a response, and the ABH type variables as predictors. Neither main effects nor interactions of ABH genotypes achieved marginal significance at level alpha = 0.10. (See Supplement Text S1 and Table S4.)
###end p 53
###begin title 54
###xml 15 28 15 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 15 28 <span type="species:ncbi:287">P. aeruginosa</span>
Acquisition of P. aeruginosa and ABH Type
###end title 54
###begin p 55
###xml 55 69 55 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa.</italic>
###xml 69 72 69 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Gibson1">[7]</xref>
###xml 154 167 154 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 384 398 380 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa,</italic>
###xml 485 498 481 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 531 538 527 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 868 881 862 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1000 1004 994 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-PittmanJ1">[30]</xref>
###xml 1040 1053 1034 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1261 1274 1255 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1771 1779 1765 1773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004270-g001">Figure 1</xref>
###xml 1948 1955 1942 1949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004270.s001">Text S1</xref>
###xml 1960 1969 1954 1963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004270.s003">Figure S2</xref>
###xml 27 35 <span type="species:ncbi:9606">patients</span>
###xml 55 68 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
###xml 154 167 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 384 397 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 485 498 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 508 515 <span type="species:ncbi:9606">patient</span>
###xml 595 603 <span type="species:ncbi:9606">patients</span>
###xml 868 881 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1040 1053 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1191 1199 <span type="species:ncbi:9606">patients</span>
###xml 1261 1274 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1326 1334 <span type="species:ncbi:9606">patients</span>
###xml 1360 1368 <span type="species:ncbi:9606">patients</span>
###xml 1403 1411 <span type="species:ncbi:9606">patients</span>
###xml 1656 1664 <span type="species:ncbi:9606">patients</span>
###xml 1815 1823 <span type="species:ncbi:9606">patients</span>
By age 18, up to 80% of CF patients are colonized with P. aeruginosa.[7] Thus, in our population of patients, there was no significant difference between P. aeruginosa colonization in the mild versus the severe groups at the age of enrollment (mean age 28.6+/-9.7 years and 16.2+/-4.1 years, respectively.) In order to determine if ABH status was associated with early infection with P. aeruginosa, data from the national CFF Registry was used to determine age of first acquisition of P. aeruginosa for each patient (as defined in Methods.) So that the question could be examined in a groups of patients that were similar in age for this comparison, data from both the entire mild group, and from a subset of the mild group ("young milds," age 15-28 years with a mean age of 20.9+/-4.0 years) was used. A clear distinction was noted in the age of onset for persistent P. aeruginosa infection (age 6.9 years in the severe group, n = 194 versus age12.4 years in the young mild group, n = 224 p<0.0001) [30] Complete data (at least 3 years of P. aeruginosa culture data available to define persistent infection, and information for at least one of the three ABH genotypes) was available on 661 patients. Associations between ABO, secretor and Lewis phenotypes and P. aeruginosa acquisition were analyzed by Kaplan-Meir plots for patients in the severe group, for patients in the entire mild group, and for patients in the young mild group. No significant differences for ABO blood group, secretor versus non-secretor status, or Lewis positive versus Lewis negative status were observed within groups. Furthermore, no significant differences were seen between patients in the severe group compared to those in the mild group nor in the young mild group based on ABH status. (Figure 1; for simplicity, combined data for patients in the severe and young mild groups is shown. Individual plots for the severe and young mild groups are shown in Supplement Text S1 and Figure S2.)
###end p 55
###begin title 56
###xml 47 60 47 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 47 60 <span type="species:ncbi:287">P. aeruginosa</span>
Association between age of onset of persistent P. aeruginosa infection and ABH type.
###end title 56
###begin p 57
###xml 113 126 113 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 113 126 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 166 174 <span type="species:ncbi:9606">patients</span>
###xml 262 270 <span type="species:ncbi:9606">patients</span>
###xml 318 326 <span type="species:ncbi:9606">patients</span>
Kaplan-Meir curves were generated (includes exit censoring) to test associations between ABH and age of onset of P. aeruginosa infection in the respiratory tract for patients with mild and severe disease. (For simplicity, figures show the proportion of infected patients in the combined group of young mild and severe patients for whom culture and ABH genotype data was available.) A) ABO blood group, B) Secretor phenotype and C) Lewis phenotype. No significant differences were seen.
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Cohen1">[17]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Rowntree1">[31]</xref>
###xml 337 341 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Kerem1">[32]</xref>
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Vanscoy1">[33]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Khan1">[34]</xref>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Drumm1">[20]</xref>
###xml 261 269 <span type="species:ncbi:9606">patients</span>
Although a great deal is known about the pathophysiology of CF lung disease, and more than 1500 CF mutations have been described [17], predictable correlation between CFTR genotype and lung phenotype has not been established. [31] Furthermore, it is known that patients with the same CF gene mutations can have highly variable outcomes. [32] Two studies of CF twins and siblings have shown that most of the disease variation reflects genetic rather than environmental influences [33], [34]; thus, multiple studies are investigating what non-CF genes may play a role in CF phenotype. [20]
###end p 59
###begin p 60
###xml 502 545 502 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus, H. influenzae, and P. aeruginosa</italic>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Huang1">[13]</xref>
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Marionneau2">[14]</xref>
###xml 724 728 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Marionneau1">[11]</xref>
###xml 801 802 801 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 928 932 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Cohen1">[17]</xref>
###xml 1107 1111 1107 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Kauffmann1">[18]</xref>
###xml 1222 1226 1222 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Ronchetti1">[19]</xref>
###xml 1228 1232 1228 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Khan1">[34]</xref>
###xml 1366 1379 1366 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1383 1392 1383 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1623 1627 1623 1627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Haponik1">[35]</xref>
###xml 370 376 <span type="species:ncbi:9606">humans</span>
###xml 467 480 <span type="species:ncbi:11983">Norwalk virus</span>
###xml 502 511 <span type="species:ncbi:1280">S. aureus</span>
###xml 513 526 <span type="species:ncbi:727">H. influenzae</span>
###xml 532 545 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 729 737 <span type="species:ncbi:9606">Patients</span>
###xml 1212 1220 <span type="species:ncbi:9606">children</span>
###xml 1272 1280 <span type="species:ncbi:9606">patients</span>
###xml 1366 1379 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1383 1392 <span type="species:ncbi:1280">S. aureus</span>
###xml 1588 1596 <span type="species:ncbi:9606">patients</span>
We chose to evaluate the ABH genes as candidates for modifiers of CF lung disease severity because the role postulated for these polymorphic genes coding for the ABH antigens is thought to be related to host-pathogen interactions; specifically, many pathogens utilize surface glycoproteins in host invasion. Numerous studies have shown that the binding and infection of humans with microbial organisms is dependent on ABH status; for example, noroviruses (previously Norwalk virus,) certain strains of S. aureus, H. influenzae, and P. aeruginosa have this capability. [13], [14] Polymorphisms in the genes coding for the ABH antigens are also known to be associated with various disease states, including pulmonary disease. [11] Patients with COPD who are nonsecretors had significantly lower mean FEV1/FVC values than secretors, suggesting that the presence of ABH antigens in respiratory epithelium may be protective in COPD. [17] Similarly, Lewis negative or nonsecretor status was significantly associated with lower lung function, and higher prevalence of wheezing and asthma, in blood group O adults. [18] The association between blood group O/nonsecretor genotype and asthma has also been demonstrated in children. [19], [34] One small study was performed in fifty patients with CF to evaluate whether secretor status was a risk factor for clinical status or P. aeruginosa or S. aureus colonization. The study found no correlation between secretor status and the clinical variables examined; however, it may have been significantly underpowered to detect a difference with only 17 patients in the nonsecretor group. [35]
###end p 60
###begin p 61
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Shori1">[36]</xref>
###xml 230 238 <span type="species:ncbi:9606">patients</span>
Based on previous studies demonstrating an association between ABH genotype and predisposition to infection and lung disease [36], we hypothesized that ABH type might affect lung severity in CF, and genotyped approximately 800 CF patients for ABH type. Although the whole genome scan approach will be used in future genetic modifier studies, the candidate gene approach was chosen to test our hypothesis as only two of the relevant ABH SNPs are included on current SNP-based whole genome platforms.
###end p 61
###begin p 62
We examined the ABO, secretor and Lewis status individually in the severe versus mild CF lung disease groups, and found no difference in prevalence of each ABH type between the two groups.
###end p 62
###begin p 63
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Zemel1">[37]</xref>
The knowledge that lung disease severity may result from a multitude of other genetic and environmental factors also lead us to hypothesize that more specific phenotypes should be examined for association with ABH genotype, such as female gender, which is associated with worse outcome in CF. [37] Therefore, we evaluated the prevalence of ABH genotypes in males versus females, but no association was found in our CF population.
###end p 63
###begin p 64
###xml 123 136 123 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 150 153 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Li1">[8]</xref>
###xml 222 235 222 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Wu1">[16]</xref>
###xml 287 300 287 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Shori1">[36]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Imundo1">[38]</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Komiyama1">[41]</xref>
###xml 494 507 494 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 635 648 635 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 30 38 <span type="species:ncbi:9606">patients</span>
###xml 123 136 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 222 235 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 287 300 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 454 462 <span type="species:ncbi:9606">patients</span>
###xml 494 507 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 635 648 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 674 682 <span type="species:ncbi:9606">patients</span>
Although approximately 80% of patients develop chronic Pseudomonal infection by early adulthood, the age of acquisition of P. aeruginosa is variable. [8] Based on previous studies demonstrating increased susceptibility to P. aeruginosa based on ABH group [16], and increased affinity of P. aeruginosa for CF respiratory and salivary mucins [36], [38]-[41], we hypothesized that there would be a difference in prevalence of the ABH antigens amongst those patients with earlier colonization with P. aeruginosa. However, there was no difference in prevalence of ABO, secretor or Lewis genotypes associated with age of onset of persistent P. aeruginosa whether we looked at all patients, or restricted our analysis to the severe group or to the mild group.
###end p 64
###begin p 65
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Clamp1">[42]</xref>
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Thiru1">[43]</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Thomsson1">[44]</xref>
###xml 552 556 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Elmgren1">[45]</xref>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 276 280 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
###xml 608 616 <span type="species:ncbi:9606">patients</span>
###xml 785 793 <span type="species:ncbi:9606">patients</span>
Another phenotype considered was that of meconium ileus (MI). It is known that only 15-20% of CF patients, regardless of CF gene mutation, develop MI. Previous studies of ileal mucus in CF neonates with MI have demonstrated increased fucosylation. [42], [43] CF gene knockout mice, whose main pathology is intestinal mucous obstruction, have increased fucosylation and increased FUT2 expression.[44] In a small study of homo- and heterozygous DeltaF508 patients, presence of both functional secretor and Lewis genes was associated with meconium ileus. [45] These studies lead us to hypothesize that MI in CF patients may be related to glycosylation patterns/ABH status; however, no difference in prevalence of ABH genotypes was found between the two groups. Because there are only 129 patients in the MI group, this evaluation may be under powered to detect a difference.
###end p 65
###begin title 66
Limitations
###end title 66
###begin p 67
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Khan1">[34]</xref>
###xml 198 211 198 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 440 453 440 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 198 211 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 311 319 <span type="species:ncbi:9606">patients</span>
###xml 347 355 <span type="species:ncbi:9606">patients</span>
###xml 385 393 <span type="species:ncbi:9606">patients</span>
###xml 440 453 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 715 723 <span type="species:ncbi:9606">children</span>
Bacterial colonization and inflammation may appear very early in CF lung disease [34], and prospective cultures were not available; we recognize the limitation of data collected retrospectively for P. aeruginosa acquisition and infection. However, we were able to collect culture data on more than 60% of these patients by age 8 years; 73% of the patients with mild disease and 60% of patients with severe disease were culture negative for P. aeruginosa at the time of first available culture. Thus, our sample should be adequate to answer the question. However, if ABH genotypes predispose to early bacterial or viral infection, it is possible that we were unable to demonstrate this finding in our group of older children and adults. To definitively determine if there is an effect of differences in ABH genotype on early acquisition of infection and subsequent lung health in CF, it would be necessary to prospectively study this question.
###end p 67
###begin p 68
###xml 429 431 429 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 521 523 521 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB</italic>
###xml 755 759 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Drumm1">[20]</xref>
###xml 761 765 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Bremer1">[46]</xref>
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
###xml 475 483 <span type="species:ncbi:9606">patients</span>
###xml 803 811 <span type="species:ncbi:9606">patients</span>
In general, the loss of some patients from an original birth cohort is a limitation to study designs examining variants in severe versus mild forms of the disease. However, according to CF registry data, for the cohort we examined, only 10% have died by age 16 years, thus, there were relatively few deaths in our cohort. Additionally, the patients in our cohort classified as having severe lung disease are still in the worst 25th percentile for their birth cohort, and the patients with mild disease are in the upper 25th percentile of their birth cohort. The validity of these concepts has previously been demonstrated; we reported that TGFB genotype is associated with disease severity, and this finding has been replicated in two additional cohorts. [20], [46] Thus, while death of the most severe patients could have potentially influenced the outcome of this study because of the extremes of phenotype design, we do not believe that limitation is a critical factor in the findings reported here.
###end p 68
###begin p 69
###xml 80 93 80 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 311 324 311 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 80 93 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 311 324 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 365 373 <span type="species:ncbi:9606">patients</span>
###xml 510 517 <span type="species:ncbi:9606">patient</span>
In conclusion, there is a clear association between the age of onset of chronic P. aeruginosa infection and the severity of lung disease, but this association was not found to be related to ABH genotype. We found no association between ABO blood group, or secretor or Lewis status with lung disease severity or P. aeruginosa infection status in a large group of CF patients homozygous for the DeltaF508 mutation. Nor did we find an association between ABH genotype and gender, asthma or meconium ileus in this patient population. This targeted study has generated important "negative" data regarding modifier genes in CF, which is not possible through SNP-based platforms (e.g. Ilumina 550K chip) because these platforms do not test for all of the pertinent SNPs necessary to establish ABO, Secretor and Lewis status.
###end p 69
###begin title 70
Supporting Information
###end title 70
###begin p 71
(0.07 MB DOC)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
###xml 85 88 85 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Boyle1">[5]</xref>
Major pathways of synthesis of the ABH and Lewis antigens (Adapted with permission.) [5] Type I is antigen precursor of ABH antigens in secretions. Le-Lewis positive and le = Lewis negative. See text for more detail. Lewis a/x denotes addition to Type 1 or Type 2 disaccharide precursor. Lewis b/y denotes addition to H antigen derived from Type 1 or Type 2 disaccharide precursor.
###end p 73
###begin p 74
(0.13 MB PDF)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
###xml 47 60 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 198 211 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 251 259 <span type="species:ncbi:9606">patients</span>
###xml 330 338 <span type="species:ncbi:9606">patients</span>
###xml 368 376 <span type="species:ncbi:9606">patients</span>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
###xml 511 519 <span type="species:ncbi:9606">patients</span>
###xml 564 572 <span type="species:ncbi:9606">patients</span>
###xml 624 632 <span type="species:ncbi:9606">patients</span>
###xml 673 681 <span type="species:ncbi:9606">patients</span>
###xml 731 739 <span type="species:ncbi:9606">patients</span>
###xml 843 851 <span type="species:ncbi:9606">patients</span>
Association between age of onset of persistent P. aeruginosa infection and ABH type. Kaplan-Meir curves were generated (includes exit censoring) to test associations between ABH and age of onset of P. aeruginosa infection in the respiratory tract for patients with mild and severe disease. Figures show the proportion of infected patients in the young mild and severe patients for whom culture and ABH genotype data was available. A) ABO blood group in patients with severe disease, B) ABO blood group in young patients with mild disease, C) Secretor phenotype in patients with severe disease D) Secretor phenotype in young patients with mild disease E) Lewis phenotype in patients with severe disease, F) Lewis phenotype in young patients with mild disease. A marginally significant p-value (p = 0.032) was demonstrated in secretor status in patients in the severe group. No other significant differences were seen by Log-Rank test. S-Secretor, NS-Nonsecretor
###end p 76
###begin p 77
(3.82 MB TIF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
PCR fragments and primers for ABO genotyping. Primers were designed to amplify three fragments from exons 6 and 7 containing the 9 SNPs (rs8176719, rs8176720, rs1053878, rs7853989, rs8176740, rs8176741, rs8176742, rs816750, rs8176472) necessary to identify blood type.
###end p 79
###begin p 80
(0.02 MB DOC)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
Sequence variations in the 7 most common ABO alleles. Base changes resulting in sequence variation. Changes are shown with reference to A1. This research was originally published in (3) (c) the American Society of Hematology.
###end p 82
###begin p 83
(0.03 MB DOC)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
###xml 153 156 153 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Gibson1">[7]</xref>
###xml 208 216 <span type="species:ncbi:9606">patients</span>
Reported incidence of ABO, secretor and Lewis phenotypes in the N = 692. The reported incidence of ABO, secretor and Lewis phenotypes is shown in black. [7] Based on our ABH genotyping, the percentage of GMS patients in each category is shown in italics.
###end p 85
###begin p 86
(0.03 MB DOC)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 305 308 305 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004270-Bobadilla1">[1]</xref>
Multivariate regression analysis. To investigate the effect of blood group alleles (ABO genotype, nonsecretor phenotype, and FUT3 genotypes producing Lewis negative phenotypes) on CF lung severity risk, we performed multiple logistic regression analyses to predict severity status. As previously reported [1], there was a highly statistically significant correlation with the TGF-beta codon 10 CC genotype, and a moderately significant association with meconium ileus status. No other variables achieved marginal significance at level alpha = 0.10, including main effects and interactions of ABH genotypes.
###end p 88
###begin p 89
(0.04 MB DOC)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
The authors would like to thank Allison Handler, RN, Michelle Kiser MD, John Yeatts, and Sally Wood for their assistance in collecting phenotype data; Jessica Pittman, MD for assistance in data analysis; Fei Zou PhD for assistance is data analysis; David Schwartz, MD for project mentorship; and David Fargo PhD and Annie Xu MD for assistance with data management.
###end p 91
###begin title 92
References
###end title 92
###begin article-title 93
Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening.
###end article-title 93
###begin article-title 94
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
###end article-title 94
###begin article-title 95
Modifier genetics: cystic fibrosis.
###end article-title 95
###begin article-title 96
Strategies for identifying modifier genes in cystic fibrosis.
###end article-title 96
###begin article-title 97
Mucus clearance as a primary innate defense mechanism for mammalian airways.
###end article-title 97
###begin article-title 98
Pathophysiology and management of pulmonary infections in cystic fibrosis.
###end article-title 98
###begin article-title 99
###xml 35 57 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 100 108 <span type="species:ncbi:9606">children</span>
Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
###end article-title 99
###begin article-title 100
The role of respiratory viruses in cystic fibrosis.
###end article-title 100
###begin article-title 101
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.
###end article-title 101
###begin article-title 102
ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world.
###end article-title 102
###begin article-title 103
###xml 26 31 <span type="species:ncbi:9606">human</span>
Sequence variation at the human ABO locus.
###end article-title 103
###begin article-title 104
###xml 20 25 <span type="species:ncbi:9606">human</span>
Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns.
###end article-title 104
###begin article-title 105
###xml 80 93 <span type="species:ncbi:11983">Norwalk virus</span>
Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment.
###end article-title 105
###begin article-title 106
###xml 29 50 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 118 124 <span type="species:ncbi:9606">infant</span>
Isolation of an adhesin from Staphylococcus aureus that binds Lewis a blood group antigen and its relevance to sudden infant death syndrome.
###end article-title 106
###begin article-title 107
###xml 36 58 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Interactions of the fucose-specific Pseudomonas aeruginosa lectin, PA-IIL, with mammalian glycoconjugates bearing polyvalent Lewis(a) and ABH blood group glycotopes.
###end article-title 107
###begin article-title 108
Is ABH nonsecretor status a risk factor for obstructive lung disease?
###end article-title 108
###begin article-title 109
Associations of blood group-related antigens to FEV1, wheezing, and asthma.
###end article-title 109
###begin article-title 110
ABO/Secretor genetic complex and susceptibility to asthma in childhood.
###end article-title 110
###begin article-title 111
Genetic modifiers of lung disease in cystic fibrosis.
###end article-title 111
###begin article-title 112
Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data.
###end article-title 112
###begin article-title 113
Secretor genotyping for A385T, G428A, C571T, C628T, 685delTGG, G849A, and other mutations from a single PCR.
###end article-title 113
###begin article-title 114
Genetic background of Lewis negative blood group phenotype and its association with atherosclerotic disease in the NHLBI family heart study.
###end article-title 114
###begin article-title 115
###xml 14 19 <span type="species:ncbi:9606">human</span>
Expression of human chromosome 19p alpha(1,3)-fucosyltransferase genes in normal tissues. Alternative splicing, polyadenylation, and isoforms.
###end article-title 115
###begin article-title 116
Five novel missense mutations of the Lewis gene (FUT3) in African (Xhosa) and Caucasian populations in South Africa.
###end article-title 116
###begin article-title 117
Modern Blood Banking and Transfusion Practice;
###end article-title 117
###begin article-title 118
Influence of Lewis alpha1-3/4-L-fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotyping, and circulating tumor marker sialyl-Lewis a levels.
###end article-title 118
###begin article-title 119
Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell.
###end article-title 119
###begin article-title 120
Age of Pseudomonas Aeruginosa Infection and Severity of Adult Lung Disease in Cystic Fibrosis.
###end article-title 120
###begin article-title 121
The phenotypic consequences of CFTR mutations.
###end article-title 121
###begin article-title 122
The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (delta F508).
###end article-title 122
###begin article-title 123
Heritability of lung disease severity in cystic fibrosis.
###end article-title 123
###begin article-title 124
###xml 32 39 <span type="species:ncbi:9606">infants</span>
Early pulmonary inflammation in infants with cystic fibrosis.
###end article-title 124
###begin article-title 125
ABH secretor status in cystic fibrosis-a negative report.
###end article-title 125
###begin article-title 126
###xml 65 73 <span type="species:ncbi:9606">patients</span>
Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7.
###end article-title 126
###begin article-title 127
###xml 86 94 <span type="species:ncbi:9606">children</span>
###xml 172 179 <span type="species:ncbi:9606">Patient</span>
Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.
###end article-title 127
###begin article-title 128
Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface.
###end article-title 128
###begin article-title 129
###xml 24 46 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Differential binding of Pseudomonas aeruginosa to normal and cystic fibrosis tracheobronchial mucins.
###end article-title 129
###begin article-title 130
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 107 129 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa.
###end article-title 130
###begin article-title 131
###xml 54 76 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 107 115 <span type="species:ncbi:9606">patients</span>
Role of sialic acid in saliva-mediated aggregation of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
###end article-title 131
###begin article-title 132
###xml 84 91 <span type="species:ncbi:9606">infants</span>
Study of the oligosaccharide units from mucus glycoproteins of meconium from normal infants and from cases of cystic fibrosis with meconium ileus.
###end article-title 132
###begin article-title 133
Abnormal fucosylation of ileal mucus in cystic fibrosis: I. A histochemical study using peroxidase labelled lectins.
###end article-title 133
###begin article-title 134
###xml 39 43 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Intestinal mucins from cystic fibrosis mice show increased fucosylation due to an induced Fucalpha1-2 glycosyltransferase.
###end article-title 134
###begin article-title 135
###xml 53 61 <span type="species:ncbi:9606">patients</span>
Lewis and secretor genotypes modify the phenotype in patients with cystic fibrosis.
###end article-title 135
###begin article-title 136
Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis.
###end article-title 136
###begin p 137
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 137
###begin p 138
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by NIH HL068890, NIH 1F32HL082207-01, and the GlaxoSmithKline Pulmonary Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 138

